Glioblastoma Cells Linked to Mitochondrial Transfer
New research shows how cancer cells hijack cellular energy systems to potentially bolster their own survival.
Updated on Oct. 9, 2026 in Cancer
Live Poll
Do you believe fundamental research into cancer cell biology improves long-term health outcomes?
Scientists have identified that glioblastoma cells use tunnelling nanotubes to exchange mitochondria with neighboring astrocytes. This metabolic link helps the cancer cells maintain their energy production.
Why it matters
By hijacking mitochondrial function from healthy cells, glioblastoma tumors may secure a critical metabolic advantage that promotes their growth. This mechanism suggests that blocking such cellular connections could eventually help make these aggressive brain tumors more sensitive to existing treatments.
Researchers identified that tunnelling nanotubes facilitate the bidirectional transfer of mitochondria between glioblastoma cells and astrocytes. This physical connection allows cancer cells to access organelles that maintain metabolic function.
The details
Tunnelling nanotubes act as physical bridges, forming direct pathways between tumor cells and surrounding cells within the microenvironment. These structures allow for the transport of large molecules and whole organelles, such as mitochondria, which are essential for cellular energy production. By absorbing healthy mitochondria, cancer cells can supplement their own metabolism and potentially increase their resistance to therapy.
Timeline
October 9, 2026: Findings on mitochondrial transfer were published.
Health Landscape
This finding sits within the broader investigation of the glioblastoma microenvironment research initiative, which seeks to understand how support cells enable tumor resilience. It highlights a departure from viewing cancer cells as isolated units, instead showing them as participants in a shared metabolic system.
While this discovery is currently limited to laboratory research, it informs the future of how clinicians might approach treatments for aggressive brain tumors. Discussing the potential for emerging metabolic-based therapies with an oncologist may be valuable for patients monitoring current research trends.
The takeaway
Cancer cells often survive by co-opting the resources of the healthy cells surrounding them. Understanding these metabolic partnerships is a critical step in developing strategies that could increase tumor sensitivity to standard medical interventions.
Further reading
For more on the latest research developments in this field, visit our Cancer section.
Source note: This article includes information reported by Nature.
Live Poll
Do you believe fundamental research into cancer cell biology improves long-term health outcomes?
